MHR Capital Partners

MHR Fund Management, commonly known as MHR Capital Partners, is a New York-based private equity and hedge fund manager founded in 1996 by Dr. Mark Rachesky. The firm employs a fundamental, value-oriented investment strategy, often focusing on distressed companies and special situations where it can take a control-oriented approach. MHR maintains a significant investment focus on the healthcare and life sciences sectors, providing capital and strategic oversight to biotechnology and pharmaceutical firms. Its portfolio has historically included notable positions in companies such as Titan Pharmaceuticals, Navidea Biopharmaceuticals, and Emisphere Technologies. The firm is recognized for its active involvement in the management and restructuring of its investee companies to unlock long-term value. Led by Dr. Rachesky, a former protégé of Carl Icahn, MHR leverages deep industry expertise to navigate complex turnarounds in the healthcare space.